e-Drug3D 402 |
DIAZOXIDE
|
cas 364-98-7 |
CLASS CARDIOVASCULAR |
ROUTE (list) INJECTION ORAL |
PK parameters Tmax 1 HOUR Solubility SPARINGLY SOLUBLE IN WATER |
Target TARGET MITOCHONDRIAL KATP-CHANNEL (PMID9400389) PDB Ligand code = 20J (link to the list of PDB complexes) Download experimental 3D coordinates of 20J with added hydrogens |
DrugCentral Sulfonylurea receptor 1, Kir6.2 UNIPROT Q09428 ABCC8_HUMAN Nicotinamide phosphoribosyltransferase UNIPROT P43490 NAMPT_HUMAN |
Download SDF file | 7-chloro-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide Formula: Calculated chemical properties: MW 230.68 NB_atoms 14 XLogP 1.87 PSA 58.963 NB_HD 1 NB_HA 4 fsp3 0.12 Lipinski(0=no;1=yes) 1 |
FDA NDA 071519 (pdf not found) INN (DIAZOXIDE) DIAZOXIDE (ABRAXIS PHARM) APPROVAL= - YEAR= 0 DISCONTINUED NDA 071908 (pdf not found) INN (DIAZOXIDE) DIAZOXIDE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 016996 (pdf not found) INN (DIAZOXIDE) HYPERSTAT (SCHERING) APPROVAL= AP YEAR= 1973 NEWMOLECULARENTITY DISCONTINUED NDA 017425 (pdf not found) INN (DIAZOXIDE) PROGLYCEM (TEVA BRANDED PHARM) APPROVAL= AP YEAR= 1976 DISCONTINUED NDA 017453 (pdf not found) INN (DIAZOXIDE) PROGLYCEM (TEVA BRANDED PHARM) APPROVAL= AP YEAR= 1976 NDA 211050 (pdf not found) INN (DIAZOXIDE) DIAZOXIDE (E5 PHARMA INC) APPROVAL= AP YEAR= 2019 NDA 210799 (pdf not found) INN (DIAZOXIDE) DIAZOXIDE (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2020 NDA 216665 (pdf not found) INN (DIAZOXIDE CHOLINE) VYKAT XR (SOLENO THERAP) APPROVAL= AP YEAR= 2025 |
Other links: |